Prevent an increase in the proportion of macrolide antibiotic-resistant Campylobacter infections — FS‑06

Status: Baseline only

  
Image
Baseline only

Most Recent Data:
2.0 percent (2016-18)

Target:
2.0 percent 1

Desired Direction:
Maintains

Baseline:
2.0 percent of domestically-acquired Campylobacter jejuni infections in humans were resistant to macrolides in 2016-18 2

Prevent an increase in the proportion of domestically-acquired Campylobacter jejuni infections in humans that are resistant to macrolides

Target-Setting Method
Maintain the baseline

Summary

Campylobacter jejuni is one of the major causes of foodborne illness in the United States, and antibiotic treatment is recommended for severe infections. Every year, many people get Campylobacter jejuni infections that are resistant to the macrolide class of antibiotics. Careful use of macrolide antibiotics and strategies that reduce antibiotic-resistant Campylobacter in animals raised for food are critical for preventing macrolide antibiotic-resistant Campylobacter jejuni infections in humans.

Workgroup: Food Safety Workgroup



1. Target has been revised. See Data Methodology and Measurement for more information.

2. Baseline has been revised. See Data Methodology and Measurement for more information.